Your browser doesn't support javascript.
loading
Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma.
Nieto-Rementería, N; Pérez-Yarza, G; Boyano, M D; Apraiz, A; Izu, R; Díaz-Pérez, J L; Asumendi, A.
Affiliation
  • Nieto-Rementería N; Department of Cell Biology and Histology, School of Medicine and Dentistry, University of the Basque Country, Leioa 48940, Bizkaia, Spain.
Br J Dermatol ; 160(3): 519-26, 2009 Mar.
Article in En | MEDLINE | ID: mdl-19067706
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Tetrahydronaphthalenes / Nuclear Proteins / Lymphoma, T-Cell, Cutaneous / Tumor Suppressor Protein p53 / Anticarcinogenic Agents / Tumor Suppressor Proteins / DNA-Binding Proteins Limits: Humans Language: En Journal: Br J Dermatol Year: 2009 Document type: Article Affiliation country: España
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Tetrahydronaphthalenes / Nuclear Proteins / Lymphoma, T-Cell, Cutaneous / Tumor Suppressor Protein p53 / Anticarcinogenic Agents / Tumor Suppressor Proteins / DNA-Binding Proteins Limits: Humans Language: En Journal: Br J Dermatol Year: 2009 Document type: Article Affiliation country: España